Heterogeneous outcomes in pediatric potential celiac disease: A multicenter longitudinal study
Journal of Pediatric Gastroenterology and Nutrition · 06.07.2026
DOI: 10.1002/jpn3.70501 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 06.07.2026. Verfasst von Barak Laxer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Division, Kaplan Medical Center, Rehovot, Israel. Hauptthemen laut MEDLINE: Celiac Disease. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: None.
Abstract (Originalsprache)
Objectives
Potential celiac disease (PCD) is defined by positive celiac serology without villous atrophy. We aimed to study the outcome of children with PCD consuming a gluten‐containing diet (GCD) over time.
Methods
Children diagnosed with PCD between December 2018 and January 2022, in three pediatric gastroenterology centers, were longitudinally followed. Data were collected until October 2024, with a minimum follow‐up of 12 months, unless celiac disease (CeD) was diagnosed earlier. Baseline data included demographics, celiac serology, and histological findings. Follow‐up data included serology and biopsy results when performed.
Results
The cohort included 88 patients with PCD, with a mean follow‐up of 39 (range 12– 69) months. During this period, 17 (19.5%) patients progressed to CeD. Normalization of anti‐tissue transglutaminase antibodies (tTG), while continuing a GCD, occurred in 33/88 (37.5%) while the rest remained with PCD. Specifically, among 16 patients with tTG levels >×10 upper limit of normal (ULN) at PCD diagnosis, three (18.8%) progressed to CeD, six (37.5%) normalized tTG while continued GCD, and the rest remained unchanged. Asymptomatic patients had higher rates of tTG normalization (61.9% vs. 35.8%, p = 0.0011). Neither tTG levels, nor having Marsh 1 histology, had a significant effect on PCD outcomes.
Conclusions
Among pediatric patients with PCD, during a mean follow‐up of 3.3 years, one‐fifth progressed to CeD. Baseline serology levels do not reliably predict future mucosal deterioration. Over a third of children with PCD may achieve serological normalization while maintaining a GCD. This heterogeneous pattern of PCD warrants periodic serological and histological follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Division, Kaplan Medical Center, Rehovot, Israel.
- Pediatric Gastroenterology Unit Emek Medical Centre, Afula, Israel.
- The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
- Institute of Pathology, Kaplan Medical Center, Rehovot, Israel.
- Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center of Israel, Petach-Tikva, Israel.
- Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Tel Aviv, Israel.
ORCID-Profile: Barak Laxer, Firas Rinawi, Anat Guz-Mark
Förderung
- None
Zitieren
APA
Laxer, B., Rinawi, F., Ziv-Sokolovskaya, N., Shamir, R., Kori, M., & Guz-Mark, A. (2026). Heterogeneous outcomes in pediatric potential celiac disease: A multicenter longitudinal study. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70501
Vancouver
Laxer B, Rinawi F, Ziv-Sokolovskaya N, Shamir R, Kori M, Guz-Mark A. Heterogeneous outcomes in pediatric potential celiac disease: A multicenter longitudinal study. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70501
BibTeX
@article{Laxer2026,
author = {Laxer, Barak and Rinawi, Firas and Ziv-Sokolovskaya, Nadya and Shamir, Raanan and Kori, Michal and Guz-Mark, Anat},
title = {Heterogeneous outcomes in pediatric potential celiac disease: A multicenter longitudinal study},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2026},
doi = {10.1002/jpn3.70501}
}
EUVIMED